When Xarelto (rivaroxaban) first hit the market, it was a swift success due to the convenience compared to traditional blood thinners. Doctors regularly prescribe Xarelto to patients across the country who are living with deep vein thrombosis (DVT), pulmonary embolism (PE), or atrial fibrillation (Afib).